FDA Inspection 1133661 — Novel Laboratories, Inc.

Novel Laboratories, Inc. — FEI 3006271438

The FDA completed an inspection of Novel Laboratories, Inc. on Nov 5, 2020 in Somerset, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Nov 5, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.